Peers of Anixa Biosciences Inc (ANIX)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
343.33x
As of Apr 29, 2024
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Apr 29, 2024 | 343.33x |
| Apr 26, 2024 | 375.09x |
| Apr 25, 2024 | 337.29x |
| Apr 24, 2024 | 367.53x |
| Apr 23, 2024 | 350.90x |
| Apr 22, 2024 | 341.82x |
| Apr 19, 2024 | 358.46x |
| Apr 18, 2024 | 355.43x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison